Valuation: Labcorp Holdings Inc.

Market Cap 25.02B 22.23B 20.75B 18.91B 35.66B 2,405B 36B 251B 97.29B 1,230B 93.93B 91.89B 3,946B P/E 2026 *
22.1x
P/E 2027 * 19.8x
Enterprise Value 30.17B 26.81B 25.02B 22.8B 43.01B 2,900B 43.41B 303B 117B 1,483B 113B 111B 4,758B EV / Sales 2026 *
2.05x
EV / Sales 2027 * 1.91x
Free-Float
99.65%
Yield 2026 *
0.94%
Yield 2027 * 0.95%
1 day+1.28%
1 week-0.37%
Current month+0.12%
1 month-6.99%
3 months+7.50%
6 months+12.70%
Current year+22.96%
1 week 302.71
Extreme 302.71
312.57
1 month 302.71
Extreme 302.71
330.56
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

Chief Technology Officer

3,000 0.0037%
1/9/26 Free

Chief Technology Officer

750 0.0009%
1/9/26 Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+1.28%-0.37%+10.40%+54.59% 25.02B
+1.48%-3.00%+11.63%+24.06% 111B
+0.78%-2.05%0.00%+72.60% 92.38B
+0.46%-0.54%+156.13%+839.45% 59.15B
-0.38%-5.45%-7.18%+53.64% 27.66B
+0.97%-1.27%+28.94%+92.98% 25.75B
-0.57%+0.09%-15.78%-7.70% 20.99B
+1.83%-0.42%+27.16%+290.84% 20.82B
+1.30%-2.86%-5.57%+34.95% 16.87B
+3.56%+6.50%-4.14%+59.98% 16.59B
Average +1.07%-1.00%+20.16%+151.54% 41.58B
Weighted average by Cap. +1.00%-1.71%+27.42%+172.54%

Financials

2026 *2027 *
Net sales 14.75B 13.1B 12.23B 11.15B 21.03B 1,418B 21.22B 148B 57.36B 725B 55.38B 54.17B 2,326B 15.48B 13.75B 12.84B 11.7B 22.06B 1,488B 22.27B 155B 60.19B 761B 58.11B 56.85B 2,441B
Net income 1.13B 1B 937M 854M 1.61B 109B 1.63B 11.34B 4.4B 55.55B 4.24B 4.15B 178B 1.24B 1.1B 1.03B 939M 1.77B 119B 1.79B 12.47B 4.83B 61.05B 4.66B 4.56B 196B
Net Debt 5.15B 4.58B 4.27B 3.89B 7.34B 495B 7.41B 51.69B 20.03B 253B 19.34B 18.92B 812B 4.51B 4.01B 3.74B 3.41B 6.43B 433B 6.49B 45.25B 17.53B 222B 16.93B 16.56B 711B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
-
Date Price Change Volume
02/10/26 USD 308.49 +1.28% 588,224
01/10/26 USD 304.60 -1.14% 559,548
30/09/26 USD 308.11 -0.23% 646,178
29/09/26 USD 308.81 -0.25% 613,108
28/09/26 USD 309.57 -0.02% 782,476
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
308.49USD
Average target price
344.81USD
Spread / Average Target
+11.77%

Quarterly revenue - Rate of surprise